RET and breast cancer: Consistent with the observation that RET overexpression leads to poor prognosis in ER±+ BC, the presence of at least one variant allele (CT or TT) was associated with a longer OS when compared to patients carrying the wt CC alleles, thus suggesting that the RET+3 SNP represent a reliable prognostic factor in these patients.